Drug resistance and stemness in GBM were also associated with Sp1 in another study [58] and in glioma, HDAC/Sp1 regulation of BMI1 enhanced stemness [59]; this exhibited some overlap with lung cancer cells and BMI1 [54]. This evidence concerns the gene SP1 and lung carcinoma.